Moreover, it seems that HMG-CoA reductase, a cornerstone enzyme of cholesterol synthesis and the target of statins, is upregulated in human HCC samples and retrospective studies suggest that the use of statins might be associated with a reduced risk of HCC development [23]. Here, HMGCR is linked to hepatocellular carcinoma.